Quick Answer
Tanke Biosciences Corp reported Total Revenue of $28.56 million for fiscal year 2012.
Tanke Biosciences Corp Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2012 | $28.56M | +19.8% |
| 2011 | $23.83M | +18.6% |
| 2010 | $20.10M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2013 | $6.04M | -39.0% | +8.3% |
| June 30, 2013 | $5.58M | -25.0% | +19.7% |
| March 31, 2013 | $4.66M | +2.6% | -53.0% |
| September 30, 2012 | $9.91M | +58.6% | +33.3% |
| June 30, 2012 | $7.43M | — | +63.7% |
| March 31, 2012 | $4.54M | -23.6% | -27.3% |
| September 30, 2011 | $6.25M | — | +5.2% |
| March 31, 2011 | $5.94M | — | — |
- Tanke Biosciences Corp showed an increase of +19.8% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2012 period, Tanke Biosciences Corp’s total revenue has grown by 42.1% (from $20.10 million to $28.56 million).
- The most recent figure is from Tanke Biosciences Corp’s fiscal year 2012 report (Form 10-K), filed with the SEC on April 15, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: